Susquehanna International Group, LLP Generation Bio Co. Transaction History

Susquehanna International Group, LLP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$1.73 - $4.07 $39,629 - $93,231	-22,907 Reduced 56.22%	17,841 $72,000
Q4 2023 Feb 14, 2024	BUY	$0.91 - $3.35 $37,080 - $136,505	40,748 New	40,748 $67,000
Q2 2023 Aug 11, 2023	SELL	$3.5 - $5.67 $49,224 - $79,742	-14,064 Reduced 52.33%	12,810 $70,000
Q1 2023 May 16, 2023	BUY	$3.61 - $7.01 $97,015 - $188,386	26,874 New	26,874 $115,000
Q3 2022 Nov 14, 2022	SELL	$4.68 - $8.34 $225,454 - $401,771	-48,174 Reduced 67.91%	22,761 $121,000
Q2 2022 Aug 15, 2022	BUY	$4.87 - $9.41 $196,640 - $379,956	40,378 Added 132.14%	70,935 $465,000
Q1 2022 May 16, 2022	SELL	$4.16 - $7.76 $43,663 - $81,448	-10,496 Reduced 25.57%	30,557 $224,000
Q4 2021 Feb 14, 2022	BUY	$5.99 - $24.97 $58,246 - $242,808	9,724 Added 31.04%	41,053 $291,000
Q3 2021 Nov 15, 2021	SELL	$20.0 - $27.43 $23,900 - $32,778	-1,195 Reduced 3.67%	31,329 $785,000
Q2 2021 Aug 11, 2021	SELL	$24.34 - $38.34 $198,930 - $313,352	-8,173 Reduced 20.08%	32,524 $875,000
Q1 2021 May 17, 2021	BUY	$24.74 - $40.2 $1.01 Million - $1.64 Million	40,697 New	40,697 $1.16 Million

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $70.2M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.